What is Medable?
Medable is a privately held, venture-backed company based in Palo Alto, California, dedicated to transforming clinical trial execution. Its core mission is to build a robust platform that facilitates the integration of patient-generated data, thereby driving advancements in clinical research, precision medicine, and predictive healthcare. By enabling a more patient-centric approach, Medable is poised to accelerate the development of new therapies and improve patient outcomes.
How much funding has Medable raised?
Medable has raised a total of $518.8M across 6 funding rounds:
Series A
$3.6M
Series B
$16.2M
Debt
$1M
Other Financing Round
$25M
Series C
$169M
Series D
$304M
Series A (2015): $3.6M, investors not publicly disclosed
Series B (2018): $16.2M, investors not publicly disclosed
Debt (2020): $1M supported by PPP
Other Financing Round (2020): $25M featuring PPD, Inc and GSR Ventures
Series C (2021): $169M backed by Sapphire Ventures LLC, PPD Group Inc, GSR Ventures, Streamline Ventures, and The Obvious
Series D (2021): $304M with participation from WTI - Western Telematic, Blackstone Accelerates Growth, Sapphire Ventures, GSR Ventures, and Tiger Global Management
Key Investors in Medable
GSR Ventures
GSR Ventures is a venture capital firm that invests in early-stage technology companies, particularly those in the internet, software, and biotechnology sectors. They are known for supporting innovative startups with the potential for significant growth and market disruption.
Blackstone Accelerates Growth
Blackstone Accelerates Growth (BxG) is an initiative focused on fostering economic development and job creation through entrepreneurship and company growth, particularly within specific regions. They support innovative companies aiming for significant expansion.
Tiger Global Management
Tiger Global Management is a global investment firm that invests in both public and private markets, with a strong focus on technology companies. They are known for their significant capital deployment in high-growth sectors.
What's next for Medable?
The recent major strategic investment positions Medable for accelerated expansion and innovation. This capital infusion is expected to fuel the enhancement of its platform capabilities, broaden its market reach, and strengthen its position as a leader in digital health and clinical research technology. Medable's focus on leveraging patient-generated data suggests a strategic direction towards more decentralized and efficient clinical trials, aligning with the evolving landscape of healthcare.
See full Medable company page
